A detailed history of Kozak & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Kozak & Associates, Inc. holds 1,248 shares of ABT stock, worth $143,856. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,248
Previous 1,042 19.77%
Holding current value
$143,856
Previous $108,000 31.48%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$100.07 - $118.13 $20,614 - $24,334
206 Added 19.77%
1,248 $142,000
Q1 2024

May 17, 2024

SELL
$109.52 - $120.96 $15,551 - $17,176
-142 Reduced 11.99%
1,042 $118,000
Q4 2023

Jan 17, 2024

SELL
$90.19 - $110.4 $45,185 - $55,310
-501 Reduced 29.73%
1,184 $130,000
Q3 2023

Oct 17, 2023

SELL
$95.53 - $114.62 $13,278 - $15,932
-139 Reduced 7.62%
1,685 $163,000
Q2 2023

Jul 05, 2023

BUY
$100.78 - $112.29 $403 - $449
4 Added 0.22%
1,824 $198,000
Q1 2023

Apr 03, 2023

SELL
$96.86 - $114.01 $3,002 - $3,534
-31 Reduced 1.67%
1,820 $184,000
Q4 2022

Jan 03, 2023

BUY
$95.06 - $111.52 $285 - $334
3 Added 0.16%
1,851 $203,000
Q3 2022

Oct 12, 2022

BUY
$96.76 - $112.03 $387 - $448
4 Added 0.22%
1,848 $188,000
Q2 2022

Oct 12, 2022

BUY
$102.07 - $123.37 $204 - $246
2 Added 0.11%
1,844 $200,000
Q4 2021

Mar 11, 2022

BUY
$115.53 - $141.46 $1,501 - $1,838
13 Added 0.71%
1,842 $215,000
Q3 2021

Nov 16, 2021

BUY
$116.66 - $129.06 $19,715 - $21,811
169 Added 10.18%
1,829 $237,000
Q4 2020

Feb 22, 2021

BUY
$105.0 - $114.42 $174,300 - $189,937
1,660 New
1,660 $206,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kozak & Associates, Inc. Portfolio

Follow Kozak & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kozak & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kozak & Associates, Inc. with notifications on news.